3759.HK
3759.HK
CNE100003PG4
PHARMARON
Loading chart...

Company Profile

-

Related stocks

603392.SS
603392.SS • China
BEIJING WANTAI BIOLOGICAL PHARM
26.96 CNY
5.1B USD 1Y -53.6%
300759.SZ
300759.SZ • China
PHARMARON
43.11 CNY
11.85B USD 1Y +22.1%
688428.SS
688428.SS • China
INNOCARE PHARMA LTD
28.12 CNY
7.44B USD 1Y +5.2%
688180.SS
688180.SS • China
SHANGHAI JUNSHI BIOSCIENCES CO
33.83 CNY
5.19B USD 1Y -17.6%
688331.SS
688331.SS • China
REMEGEN CO LTD
107.86 CNY
9.11B USD 1Y +4.2%
9995.HK
9995.HK • China
REMEGEN
70.4 HKD
5.34B USD 1Y -33.7%
6821.HK
6821.HK • China
ASYMCHEM
155.1 HKD
7.15B USD 1Y +60.9%
300122.SZ
300122.SZ • China
ZHIFEI-BIOL
13.7 CNY
4.91B USD 1Y -34.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
4 Metrics
Country

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
67.9% p.a.
Max Drawdown (5Y)
-89.3%
Sharpe Ratio (5Y)
-0.27
Beta Factor
0.68
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (67.9% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -89.3% in the extended horizon.
ende